JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Nasser K. Altorki
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soslow, R. A.
Right arrow Articles by Altorki, N. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soslow, R. A.
Right arrow Articles by Altorki, N. K.

J Thorac Cardiovasc Surg 1997;114:838-843
© 1997 Mosby, Inc.


GENERAL THORACIC SURGERY

EXPRESSION OF ACIDIC FIBROBLAST GROWTH FACTOR IN BARRETT'S ESOPHAGUS AND ASSOCIATED ESOPHAGEAL ADENOCARCINOMA

Robert A. Soslow , MD, Liang Ying , BS, Nasser K. Altorki , MD, From the Departments of Pathology and Cardiothoracic Surgery, New York Hospital–Cornell Medical Center, New York, N.Y.

Received for publication May 7, 1997 revisions requested June 2, 1997; revisions received June 18, 1997 accepted for publication June 19, 1997. Address for reprints: Nasser K. Altorki, MD, New York Hospital–Cornell Medical Center, 525 East 68th St., Division of Cardiothoracic Surgery, New York, NY 10021.

Abstract

Objective: Adenocarcinoma of the esophagus is generally attributed to the neoplastic transformation of intestinal metaplastic lesions (Barrett's esophagus). On the basis of our preliminary data that showed significant acidic fibroblast growth factor mRNA and protein expression in adenocarcinoma of the esophagus, we studied expression of fibroblast growth factor in esophageal adenocarcinoma and its precursor lesions, intestinal metaplasia, low-grade dysplasia, and high-grade dysplasia. Fibroblast growth factor belongs to a family of polypeptides that are involved in differentiation and cellular proliferation. Methods: We examined 30 esophagectomy specimens that were resected for adenocarcinoma (n = 27) and high-grade dysplasia (n = 3). After confirmation of the diagnosis by routine light microscopy, the index lesions (invasive carcinomas) and adjoining Barrett's mucosa were evaluated with a monoclonal antibody against human acidic fibroblast growth factor. The results are expressed with the use of an immunoreactive score that allows distinction between weak, moderate, and strong immunoreactivity. Results: Adenocarcinoma demonstrated a moderate-to-strong mean immunoreactive score of 8. In contrast, high-grade dysplasia demonstrated a weak-to-moderate mean score of 4.5, which was significantly different (p < 0.05). Intestinal metaplasia and low-grade dysplasia displayed even weaker expression of fibroblast growth factor, with a negligible immunoreactive score less than 1 (p < 0.005). Seventy-five percent of evaluable cases demonstrated an increasing degree of fibroblast growth factor expression in the spectrum of lesions ranging from metaplasia to dysplasia and carcinoma. Conclusions: These data indicate that in patients with adenocarcinoma arising in association with Barrett's esophagus, fibroblast growth factor is generally sequentially accumulated in the progression from metaplasia to neoplasia. This progression may affect future investigation into the role of fibroblast growth factors in tumorigenesis and, possibly, the application of fibroblast growth factor immunohistochemistry to diagnosis.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. I. T. Sihvo, T. Ruohtula, M. I. Auvinen, A. Koivistoinen, A. L. Harjula, and J. A. Salo
Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus
J. Thorac. Cardiovasc. Surg., January 1, 2004; 126(6): 1952 - 1957.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. V. N. Lord, J. M. Park, K. Wickramasinghe, S. R. DeMeester, S. Oberg, D. Salonga, J. Singer, J. H. Peters, K. D. Danenberg, T. R. DeMeester, et al.
Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus
J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 246 - 253.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 by The American Association for Thoracic Surgery.